• ABOUT ECCOGENE
    • ABOUT ECCOGENE
    • MANAGEMENT TEAM
    • SCIENTIFIC ADVISORY BOARD
    • INVESTOR
  • FOCUSED AREA
  • OUR PIPELINE
  • NEWS
    • COMPANY DYNAMIC RELEASE
    • MEDIA COVERAGE
  • PARTERNERSHIPS
  • JOIN US
    • OUR CULTURE
    • CAREER OPPORTUNITIES
  • 中文
SCIENTIFIC ADVISORY BOARD
ABOUT ECCOGENE MANAGEMENT TEAM SCIENTIFIC ADVISORY BOARD INVESTOR
  • Michael R. Wiley, Ph.D

    Dr. Wiley earned his PhD in chemistry from University of Utah and finished postdoctoral training at Columbia University. He is a well-recognized drug discovery leader with 30 years of experience in the pharmaceutical industry. Most recently, he was Research Fellow at Eli Lilly and company. He has been a successful scientific leader to deliver multiple clinical candidates across diverse therapeutic areas. His expertise spans a wide range of target families, biochemical pathways, chemotypes and mechanisms of action. In addition, Dr. Wiley is also appreciated for his passion of sharing, coaching and mentoring people in the industry across diverse disciplines, cultures and geographies.

  • COPYRIGHT © 2021 Eccogene (Shanghai) Co., Ltd
  • Room 402A, No. 326, Edison Road, Pudong New District, Shanghai, China
  • contact@eccogene.com